Higashimori Takamitsu, Kono Taro, Sakurai Hiroyuki, Nakazawa Hiroaki, Groff William Frederick
Department of Plastic and Reconstructive Surgery, Tokyo Women's Medical University, Medical Center East, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Plast Surg Int. 2010;2010:874348. doi: 10.1155/2010/874348. Epub 2010 Jul 1.
Objectives. Several modalities have been advocated to treat traumatic scars, including surgical techniques and laser resurfacing. Recently, a plasma skin regeneration (PSR) system has been investigated. There are no reports on plasma treatment of mesh skin grafted scars. The objective of our study is to evaluate the effectiveness and complications of plasma treatment of mesh skin grafted scars in Asian patients. Materials and Methods. Four Asian patients with mesh skin grafted scars were enrolled in the study. The plasma treatments were performed at monthly intervals with PSR, using energy settings of 3 to 4 J. Improvement was determined by patient questionnaires and physician evaluation of digital photographs taken prior to treatment and at 3 months post treatment. The patients were also evaluated for any side effects from the treatment. Results. All patients showed more than 50% improvement. The average pain score on a 10-point scale was 6.9 +/- 1.2 SD and all patients tolerated the treatments. Temporary, localized hypopigmentation was observed in two patients. Hyperpigmentation and worsening of scarring were not observed. Conclusions. Plasma treatment is clinically effective and is associated with minimal complications when used to treat mesh skin grafted scars in Asian patients.
目的。已经提倡多种方式来治疗创伤性瘢痕,包括手术技术和激光换肤。最近,一种等离子皮肤再生(PSR)系统已被研究。尚无关于等离子体治疗网状皮肤移植瘢痕的报道。我们研究的目的是评估等离子体治疗亚洲患者网状皮肤移植瘢痕的有效性和并发症。材料与方法。四名患有网状皮肤移植瘢痕的亚洲患者被纳入研究。使用PSR以每月一次的间隔进行等离子体治疗,能量设置为3至4焦耳。通过患者问卷以及医生对治疗前和治疗后3个月拍摄的数码照片的评估来确定改善情况。还对患者进行了治疗副作用的评估。结果。所有患者均显示改善超过50%。10分制的平均疼痛评分为6.9 +/- 1.2标准差,所有患者均耐受治疗。两名患者出现了暂时性、局部性色素减退。未观察到色素沉着和瘢痕恶化。结论。等离子体治疗在临床上是有效的,并且用于治疗亚洲患者的网状皮肤移植瘢痕时并发症极少。